Inactive Instrument
PhaseRx Inc Stock Nasdaq
Stocks
US71723F1030
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 4.56M 3.92M 3.68M 3.37M 6.29M 431M 6.34M 43.55M 16.96M 220M 17.12M 16.75M 709M | P/E 2015 * |
-
| P/E 2016 | -0.58x |
|---|---|---|---|---|---|
| Enterprise Value | -5.22M -4.49M -4.21M -3.85M -7.19M -493M -7.25M -49.83M -19.4M -252M -19.59M -19.16M -812M | EV / Sales 2015 * |
-
| EV / Sales 2016 | - |
| Free-Float |
100% | Yield 2015 * |
-
| Yield 2016 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -77.95% | - | - | 11 | |
| +1.03% | -2.05% | +39.28% | +94.60% | 68.87B | |
| +1.31% | +0.55% | +49.48% | +92.12% | 65.29B | |
| -1.11% | +3.27% | -12.64% | +375.39% | 27.65B | |
| +2.97% | -0.10% | +41.86% | +14.84% | 25.77B | |
| -0.57% | -7.43% | +2.69% | -15.48% | 26.08B | |
| +1.01% | +1.38% | +26.48% | -17.50% | 20.14B | |
| +3.45% | -14.83% | +225.22% | +389.50% | 17.03B | |
| +0.77% | -4.55% | -0.36% | +549.41% | 15.03B | |
| +1.64% | +7.65% | +60.96% | +167.13% | 14.5B | |
| Average | +1.06% | -2.66% | +48.11% | +183.33% | 31.15B | |
| Weighted average by Cap. | +1.09% | -2.12% | +42.73% | +142.13% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 375K 323K 303K 277K 517K 35.45M 521K 3.58M 1.39M 18.12M 1.41M 1.38M 58.34M | - |
| Net income | -7.38M -6.35M -5.96M -5.45M -10.17M -697M -10.25M -70.46M -27.44M -356M -27.7M -27.1M -1.15B | -20.14M -17.33M -16.26M -14.88M -27.76M -1.9B -27.98M -192M -74.9M -973M -75.62M -73.97M -3.13B |
| Net Debt | 16.55M 14.24M 13.36M 12.23M 22.82M 1.56B 23M 158M 61.56M 800M 62.15M 60.8M 2.58B | -9.78M -8.41M -7.89M -7.22M -13.48M -924M -13.59M -93.37M -36.36M -472M -36.71M -35.91M -1.52B |
Employees
-
